
United States · Information technology & services startup
Sirona Medical is a healthcare technology company based in San Francisco, founded in 2018.
Funding reportedLast round: Series B
Sirona Medical is a healthcare technology company based in San Francisco, founded in 2018.
The company focuses on simplifying radiology workflows and infrastructure through its cloud-native, AI-powered platform, RadOS (Radiology Operating System). This platform integrates imaging, diagnostic reporting, dictation, and workflow into a single workspace, allowing clinicians to concentrate on patient care. Sirona Medical offers a range of software solutions tailored for medical imaging analysis and workflow management. Key products include the Diagnostic Viewer, which enhances medical image visualization, and the Reporter, a diagnostic reporting tool. The platform employs artificial intelligence to streamline operations and is accessible via a web browser, enabling radiologists to work remotely without complex installations. Sirona primarily serves radiologists, radiology practices, and healthcare institutions, providing scalable and secure radiology IT solutions.
Funding, as reported
From Sirona Medical's own website and the SEC filings it signed: 1 founder, 8 on the team.
On the board, as filediAndrew PerlmanFrancisco Gimenez
What they build
Known for
automated spine labelinghealth caremedical imaging integrationsoc2 securityhipaa complianceradiology workflow optimizationhybrid rendering technologycomputer & network securityradiology it modernizationenterprisesai case labelingcloud-native radiology platformautomated case labelingmacro and template importinformation technology & servicescomputer vision
Built with from their website
Amazon SESGoogle Tag ManagerAmazon CloudFrontWordPress.orgSalesforce CRM AnalyticsAtlassianPWAYouTubeGoogle WorkspaceCloudFlare
Viewport MetaViteTrados StudioAmazon Simple Email ServiceWP EngineHubspotWebGLwebpack
Add your raise, your deck and your story, and put Sirona Medical in front of investors. Or tell us what we have wrong.